Overall control of bleeding and mortality was not significantly different between octreotide ( 85 % , 62 patients ) and sclerotherapy ( 82 % , 63 patients ) over the 48 hour trial period ( relative risk of rebleeding 0.83 ; 95 % confidence interval ( CI ) 0.38 to 1.82 ) , irrespective of Child 's grading or active bleeding at endoscopy .
